Company

NanoViricides, Inc.

Headquarters: Shelton, CT, United States

Employees: 17

CEO: Dr. Anil R. Diwan Ph.D.

NYSE: NNVC +2.65%

Market Cap

$13.2 Million

USD as of Jan. 1, 2024

Market Cap History

NanoViricides, Inc. market capitalization over time

Evolution of NanoViricides, Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of NanoViricides, Inc.

Detailed Description

NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

NanoViricides, Inc. has the following listings and related stock indices.


Stock: NYSE: NNVC wb_incandescent

Details

Headquarters:

1 Controls Drive

Shelton, CT 06484

United States

Phone: 203 937 6137

Fax: 203 859 5095